Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.

about

18F-FDG-PET for Assessing Biological Viability and Prognosis in Liver Transplant Patients with Hepatocellular Carcinoma

P2860

Q41706815-1E3C36E1-F249-49D7-954C-DD4A44106349

P2860

Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.

Item

http://www.wikidata.org/entity/Q38988008

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Current clinical status of 18F ...... and abdominal organ oncology.

@en

type

Item

label

Current clinical status of 18F ...... and abdominal organ oncology.

@en

prefLabel

Current clinical status of 18F ...... and abdominal organ oncology.

@en

P1476

Current clinical status of 18F ...... and abdominal organ oncology.

@en

P2093

Masatoyo Nakajo

http://www.w3.org/2001/XMLSchema#string

Masayuki Nakajo

http://www.w3.org/2001/XMLSchema#string

Megumi Jinguji

http://www.w3.org/2001/XMLSchema#string

Takashi Yoshiura

http://www.w3.org/2001/XMLSchema#string

Tohru Nihara

http://www.w3.org/2001/XMLSchema#string

Yoriko Kajiya

http://www.w3.org/2001/XMLSchema#string

Yoshiaki Nakabeppu

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Role of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography in gastrointestinal cancers

Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.

The Feasibility of (18)F-Fluorothymidine PET for Prediction of Tumor Response after Induction Chemotherapy Followed by Chemoradiotherapy with S-1/Oxaliplatin in Patients with Resectable Esophageal Cancer.

Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer.

18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data.

18F-FLT PET imaging of cellular proliferation in pancreatic cancer.

Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors

A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.

Gastric carcinoma: imaging diagnosis, staging and assessment of treatment response.

P2888

s00261-016-0947-9

P304

951-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00261-016-0947-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27770160

http://www.w3.org/2001/XMLSchema#string

Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.

about

P2860

P2860

Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698